𝔖 Bobbio Scriptorium
✦   LIBER   ✦

313 Breast conserving therapy for early stage invasive cancer and ductal carcinoma in situ

✍ Scribed by Barbara L. Fowble

Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
52 KB
Volume
32
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Breast-conserving therapy (BCT) for earl
Breast-conserving therapy (BCT) for early-stage breast cancer
✍ Rashmi K. Benda; Nancy Price Mendenhall; D. Scott Lind; Juan C. Cendan; Barbara πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 188 KB

## Abstract Several patient and tumor factors go into the decision process to determine whether a breast cancer patient is a good candidate for breast‐conserving therapy. The patient must be seen by all disciplines before any therapeutic intervention. When used appropriately, breast‐conserving ther

The molecular journey from ductal carcin
The molecular journey from ductal carcinoma in situ to invasive breast cancer
✍ Lisa Wiechmann; Henry M. Kuerer πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 767 KB

## Abstract Ductal carcinoma in situ (DCIS) accounts for approximately 20% of mammographically detected breast cancers. DCIS can recur or progress to invasive breast cancer, but the ability to predict the outcome of patients with DCIS remains limited, leading to inappropriate treatment choices. To